A Fabry Disease Patient Who Developed Hypersensitivity Reaction against Agalsidase Beta following COVID-19 Infection

Abstract Fabry disease (FD) is a rare, X-linked inherited lysosomal storage disorder, characterized by the accumulation of globotriaosylceramide (Gb3) due to the deficiency or absence of alpha-galactosidase A. Due to the accumulation of Gb3, cardiac, renal, neurological, and skin manifestations can...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nephron (2015) 2023-04, Vol.147 (3-4), p.199-202
Hauptverfasser:	Sonmez, Ozge, Ozcan, Seyda Gul, Trabulus, Sinan, Seyahi, Nurhan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult alpha-Galactosidase - therapeutic use Clinical Practice: Case Report COVID-19 - complications Enzyme Replacement Therapy - adverse effects Fabry Disease - complications Fabry Disease - drug therapy Humans Hypersensitivity - drug therapy Immunoglobulin E - therapeutic use Male Recombinant Proteins - adverse effects Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!